Tag:
Okarios
Latest Headlines
Latest Headlines
Merck spinout nails promising study on hep C vaccine
A group of European investigators working in league with a small biotech spun out of Merck ( $MRK ) four years ago has claimed an early-stage success with a small human trial that has generated
Italy's Okairos raises $20.5M for vaccine work
Versant Ventures and Boehringer Ingelheim Venture Fund led a €16 million ($20.5 million) Series B round of funding for Okairos, which is developing next gen vaccines for infectious disease.
